Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $6.3B. Its FinScore is 55/100; its highest-scoring layer is Growth (94) and its lowest is Value (0).
Share price performance
About Mirum Pharmaceuticals, Inc.
www.mirumpharma.comMirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- HQ
- United States
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 23 hours ago
- Market cap
- $6.3B
- Shares outstanding
- 64.9M
- Beta (issuer)
- 0.49
- Revenue (latest FY)
- $521.3M
Revenue breakdown
- Product100.0%$521.3M
FinScore
As of 2026-11-04Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Mirum Pharmaceuticals, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Mirum Pharmaceuticals, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Mirum Pharmaceuticals, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Mirum Pharmaceuticals, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Mirum Pharmaceuticals, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Mirum Pharmaceuticals, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.